Development and Evaluation of Sample treatment platform for infectious disease immunoassays
|Funding from Vinnova||SEK 1 450 005|
|Project duration||January 2019 - December 2020|
|Venture||Medtech4Health - medicintekniska samverkansprojekt|
|Call||Medtech4Health: Collaboration projects involving medical technology 2018|
Purpose and goal
We aim to validate the SpeClean technology as a new standard treatment of samples. This would allow many more infectious disease diagnostics to be performed at primary health care centers or at the patient’s bedside.
Expected results and effects
In this project we will evaluate new sample preparation technology directed at improving the performance of currently available immunoassays for infectious diseases. The sample treatment aims to remove inhibitory substances from biological samples like urine, saliva or blood, which results in a significant improvement in the sensitivity of the test and reduces unspecific background. In turn, this allows for simpler and more robust tests to be utilized in place of traditional assays.
Planned approach and implementation
Project is a cooperation of Biopromic AB, Karolinska Institute and Örebro University Hospital and will last for 18 months starting February 2019.